Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Summary

This is a ten subject, phase 1 study. The purpose of the Phase 1 study is to demonstrate drug safety in a target group of subjects with high grade brain cancer. This population represents a potential clinical population that may benefit from this PET imaging tracer. The study will also begin collection of baseline imaging data and allow us to gain information to improve design and conduct of future trials.

Timeline

Start

2007-11

Primary completion

2008-05

Completion

2008-05

Drugs

Indications